English
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message
News Categories
Featured News
Now Available!|Research-Grade ActCel T Cell Activation Reagent – Free Trials for New Product

Now Available!|Research-Grade ActCel ...
Our Latest Webinar: "Understanding Autoimmune CAR-T Therapy"

Our Latest Webinar: "Understanding Au...
Meet Us at the ESGCT Congress in Rome!

Meet Us at the ESGCT Congress in Rome!
The First Step of CAR-T Commercialization

The First Step of CAR-T Commercializa...
The effect of interleukin on the function of NK cells（IL-1β, IL-12, IL-15, IL-18, IL-21）

The effect of interleukin on the func...
Summary of Protein Factors Involved in Hematopoietic Stem Cell Culture

Summary of Protein Factors Involved i...
Overseas Exhibition Preview | T&L Will Participate in SITC 2023 San Diego, USA

Overseas Exhibition Preview | T&L Wil...
New Product Launch | Nanoscale Sorting Magnetic Beads Weighing Heavily~

New Product Launch | Nanoscale Sortin...
Good News | T&L CGT Core Raw Material CD28 Monoclonal Antibody Has Completed FDA DMF Filing

Good News | T&L CGT Core Raw Material...
Good News | T&L Cell Therapy Key Materials Have Been Registered with Fda Dmf, Helping Your Drug Application Process

Good News | T&L Cell Therapy Key Mate...
0102030405

News

[Blockbuster] T&L CGT core raw materials have been re-registered with the US FDA DMF

[Blockbuster] T&L CGT core raw materials have been re-registered with the US FDA DMF
2024-06-28

We are pleased to announce that after obtaining DMF registration for CD3 monoclonal antibody and CD3/CD28 sorting activated magnetic beads, T&L's GMP grade products, recombinant human IL-7 protein (Cat. No. GMP-TL506) ...

view detail
FirstPrev12NextLastTotal 2